VERO Stock Analysis: Buy, Sell, or Hold?
VERO - Venus Concept Inc. Common Stock
$1.14
-0.04 (-3.39%)
▼
5d:
-10.24%
30d:
-25.0%
90d:
-45.97%
WAIT
LOW Confidence
Analysis Updated: Feb 6, 2026 12:00 AM ET
Earnings: Mar 30, 2026
0d
Get Alerted When VERO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: VERO is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: VERO is down 10.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: VERO is currently trading at $1.14, which is considered fair based on recent price action.
Technical Outlook: Technically, VERO is showing sideways momentum. The price is currently testing key support at $1.16. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.60 (+829.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VERO is showing sideways momentum. The price is currently testing key support at $1.16. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $10.60 (+829.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
42/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BEARISH: Downward momentum (-3.4%)
- BULLISH: Trading 829.8% below Wall St target ($10.60)
- WARNING: Recommendation downgraded due to -10.2% 5-day decline - wait for stabilization
Support & Resistance Levels
Support Level
$1.16
Resistance Level
$1.67
Current Trend
Sideways
Technical data as of
Feb 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.25
Wall Street Target
$10.60
(+829.8%)
Revenue Growth (YoY)
-8.2%
Profit Margin
-92.8%
Share & Embed Analysis
Last updated: April 01, 2026 1:52 AM ET
Data refreshes hourly during market hours. Next update: 2:52 AM
Data refreshes hourly during market hours. Next update: 2:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VERO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 52 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 64 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 51 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 58 HOLD |
